{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:10:14Z","timestamp":1778713814155,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["#303846\/2008-9"],"award-info":[{"award-number":["#303846\/2008-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"crossref","award":["# E-26\/103.252\/2011"],"award-info":[{"award-number":["# E-26\/103.252\/2011"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.psychres.2018.02.013","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T12:53:41Z","timestamp":1518180821000},"page":"237-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Predictors of benzodiazepine use in a transdiagnostic sample of panic disorder, social anxiety disorder, and obsessive-compulsive disorder patients"],"prefix":"10.1016","volume":"262","author":[{"given":"Luana D.","family":"Laurito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla P.","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela V.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Vigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela B.","family":"de Menezes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael C.","family":"Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Stangier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo F.","family":"Fontenelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1037\/a0018260","article-title":"Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the Dimensional Obsessive-Compulsive Scale","volume":"22","author":"Abramowitz","year":"2010","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.psychres.2018.02.013_bib2","doi-asserted-by":"crossref","unstructured":"AGS_2015_Beers_Criteria_Update_Expert_Panel, 2015. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 63 (11), 2227\u20132246.","DOI":"10.1111\/jgs.13702"},{"key":"10.1016\/j.psychres.2018.02.013_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jad.2013.09.014","article-title":"Emotional reasoning and anxiety sensitivity: associations with social anxiety disorder in childhood","volume":"152\u2013154","author":"Alkozei","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/S1516-44462006005000062","article-title":"Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: the Bambui Health and Aging Study (BHAS)","volume":"30","author":"Alvarenga","year":"2008","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.psychres.2018.02.013_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S1516-44462000000300003","article-title":"Mini International Neuropsychiatric Interview (MINI): valida\u00e7\u00e3o de entrevista breve para diagn\u00f3stico de transtornos mentais","volume":"22","author":"Amorim","year":"2000","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"5","key":"10.1016\/j.psychres.2018.02.013_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2018.02.013_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004850-199506000-00003","article-title":"Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale","volume":"10","author":"Bandelow","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2018.02.013_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00406-014-0563-z","article-title":"The German guidelines for the treatment of anxiety disorders","volume":"265","author":"Bandelow","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.psychres.2018.02.013_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/YIC.0000000000000078","article-title":"Efficacy of treatments for anxiety disorders: a meta-analysis","volume":"30","author":"Bandelow","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2018.02.013_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/13651501.2012.667114","article-title":"Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care","volume":"16","author":"Bandelow","year":"2012","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"4","key":"10.1016\/j.psychres.2018.02.013_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15622970802465807","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision","volume":"9","author":"Bandelow","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2018.02.013_bib12","series-title":"Self-Efficacy: The Exercise of Control","author":"Bandura","year":"1997"},{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/JGP.0b013e31815aff5c","article-title":"Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study","volume":"16","author":"Benitez","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2018.02.013_bib14","first-page":"39","article-title":"A major change of prescribing pattern in absence of adequate evidence: benzodiazepines versus newer antidepressants in anxiety disorders","volume":"41","author":"Berney","year":"2008","journal-title":"Psychopharmacol. Bull."},{"issue":"6","key":"10.1016\/j.psychres.2018.02.013_bib15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4088\/JCP.v67n0611","article-title":"Treatment of obsessive-compulsive disorder by U.S. psychiatrists","volume":"67","author":"Blanco","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2018.02.013_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hup.2541","article-title":"International prescribing practices in obsessive-compulsive disorder (OCD)","volume":"31","author":"Brakoulias","year":"2016","journal-title":"Hum. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.psychres.2018.02.013_bib17","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1176\/appi.ajp.160.8.1432","article-title":"Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?","volume":"160","author":"Bruce","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jad.2013.05.054","article-title":"Patterns of benzodiazepine and antidepressant use among middle-aged adults. the Brazilian longitudinal study of adult health (ELSA-Brasil)","volume":"151","author":"Brunoni","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2018.02.013_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2017.1273","article-title":"Simultaneous antidepressant and benzodiazepine new use and subsequent long-term benzodiazepine use in adults with depression, United States, 2001\u20132014","author":"Bushnell","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2018.02.013_bib20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1212\/WNL.47.3.844","article-title":"Persistent dyskinesia and obsessive-compulsive behavior following alcohol withdrawal","volume":"47","author":"Cardoso","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.psychres.2018.02.013_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10401230490486972","article-title":"A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder","volume":"16","author":"Crockett","year":"2004","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2018.02.013_bib22","series-title":"Manual da vers\u00e3o em portugu\u00eas das escalas Beck","author":"Cunha","year":"2001"},{"issue":"Suppl. 2","key":"10.1016\/j.psychres.2018.02.013_bib23","first-page":"26","article-title":"Use of benzodiazepines in panic disorder","volume":"58","author":"Davidson","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2018.02.013_bib24","first-page":"Suppl, 16","article-title":"Long-term treatment of social phobia with clonazepam","volume":"52","author":"Davidson","year":"1991","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2018.02.013_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004714-199312000-00008","article-title":"Treatment of social phobia with clonazepam and placebo","volume":"13","author":"Davidson","year":"1993","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2018.02.013_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.brat.2008.01.010","article-title":"The effects of safety behaviors on the fear of contamination: an experimental investigation","volume":"46","author":"Deacon","year":"2008","journal-title":"Behav. Res. Ther."},{"issue":"1\u20132","key":"10.1016\/j.psychres.2018.02.013_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jad.2008.01.011","article-title":"Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD)","volume":"110","author":"Demyttenaere","year":"2008","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.psychres.2018.02.013_bib28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00005053-198811000-00008","article-title":"Obsessive-compulsive disorder occurring as a complication in benzodiazepine withdrawal","volume":"176","author":"Drummond","year":"1988","journal-title":"J. Nerv. Ment. Dis."},{"issue":"7","key":"10.1016\/j.psychres.2018.02.013_bib29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamapsychiatry.2015.0182","article-title":"Benzodiazepines in anxiety disorders","volume":"72","author":"Fava","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2018.02.013_bib30","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/0278-5846(94)90118-X","article-title":"Benzodiazepines and anxiety sensitivity in panic disorder","volume":"18","author":"Fava","year":"1994","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2018.02.013_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0000000000000740","article-title":"A 6-year posttreatment follow-up of panic disorder patients: treatment with clonazepam predicts lower recurrence than treatment with paroxetine","author":"Freire","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2018.02.013_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/pcn.12203","article-title":"Dependence on benzodiazepines in patients with panic disorder: a cross-sectional study","volume":"69","author":"Fujii","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2018.02.013_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brat.2014.02.004","article-title":"Benzodiazepine treatment can impair or spare extinction, depending on when it is given","volume":"56","author":"Hart","year":"2014","journal-title":"Behav. Res. Ther."},{"issue":"6","key":"10.1016\/j.psychres.2018.02.013_bib34","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00004714-199212000-00008","article-title":"Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder","volume":"12","author":"Hewlett","year":"1992","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/15622970309167908","article-title":"A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder","volume":"4","author":"Hollander","year":"2003","journal-title":"World J. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2018.02.013_bib36","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/1039856215588209","article-title":"Latest guidelines for the management of the anxiety disorders - a report from The International Anxiety Disorders Society Conference, Melbourne 2014","volume":"23","author":"Hood","year":"2015","journal-title":"Australas Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2018.02.013_bib37","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1081\/JA-100104489","article-title":"Use and misuse of benzodiazepines in Brazil: a review","volume":"36","author":"Kapczinski","year":"2001","journal-title":"Subst. Use Misuse"},{"issue":"Suppl. 1","key":"10.1016\/j.psychres.2018.02.013_bib38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11920-015-0642-5","article-title":"Withdrawing benzodiazepines in patients with anxiety disorders","volume":"18","author":"Lader","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.psychres.2018.02.013_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.janxdis.2015.04.003","article-title":"Distress tolerance in OCD and anxiety disorders, and its relationship with anxiety sensitivity and intolerance of uncertainty","volume":"33","author":"Laposa","year":"2015","journal-title":"J. Anxiety Disord."},{"issue":"6","key":"10.1016\/j.psychres.2018.02.013_bib41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/JCP.0b013e3182362484","article-title":"Determinants of initiated and continued benzodiazepine use in the Netherlands study of depression and anxiety","volume":"31","author":"Manthey","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2018.02.013_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2125.2010.03818.x","article-title":"Correlates of (inappropriate) benzodiazepine use: the Netherlands Study of Depression and Anxiety (NESDA)","volume":"71","author":"Manthey","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2018.02.013_bib43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1192\/S0007125000122810","article-title":"Obsessive-compulsive disorder--a complication of benzodiazepine withdrawal","volume":"150","author":"Matthews","year":"1987","journal-title":"Br. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2018.02.013_bib44","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.alc.0000175016.01790.f1","article-title":"Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders","volume":"29","author":"Mueller","year":"2005","journal-title":"Alcohol Clin. Exp. Res"},{"key":"10.1016\/j.psychres.2018.02.013_bib45","series-title":"Anxiety Disorders. Quality Standard (QS53)","author":"NICE","year":"2014"},{"issue":"6","key":"10.1016\/j.psychres.2018.02.013_bib46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000353198","article-title":"Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis","volume":"82","author":"Offidani","year":"2013","journal-title":"Psychother. Psychosom."},{"issue":"6","key":"10.1016\/j.psychres.2018.02.013_bib47","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1037\/a0017428","article-title":"Anxiety sensitivity and the anxiety disorders: a meta-analytic review and synthesis","volume":"135","author":"Olatunji","year":"2009","journal-title":"Psychol. Bull."},{"issue":"2","key":"10.1016\/j.psychres.2018.02.013_bib48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2018.02.013_bib49","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4088\/JCP.v65n0903","article-title":"National trends in the outpatient treatment of anxiety disorders","volume":"65","author":"Olfson","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40263-015-0305-4","article-title":"The benzodiazepine-dementia disorders link: current state of knowledge","volume":"30","author":"Pariente","year":"2016","journal-title":"CNS Drugs"},{"issue":"9","key":"10.1016\/j.psychres.2018.02.013_bib51","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/NMD.0000000000000348","article-title":"Determinants of treatment-resistant depression: the salience of benzodiazepines","volume":"203","author":"Parker","year":"2015","journal-title":"J. Nerv. Ment. Dis."},{"issue":"9","key":"10.1016\/j.psychres.2018.02.013_bib52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.addbeh.2009.04.014","article-title":"Development of self-efficacy and expectancy measures for benzodiazepines","volume":"34","author":"Parr","year":"2009","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.psychres.2018.02.013_bib53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.erap.2005.01.001","article-title":"Quality of life and benzodiazepine drug use by community-dwelling elderly: a stress and coping perspective","volume":"57","author":"P\u00e9rodeau","year":"2007","journal-title":"Rev. Eur. Psychol. Appliqu\u00e9e\/Eur. Rev. Appl. Psychol."},{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ajp.2013.12101353","article-title":"A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder","volume":"171","author":"Pollack","year":"2014","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/105504901750160484","article-title":"Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence","volume":"10","author":"Posternak","year":"2001","journal-title":"Am. J. Addict."},{"issue":"8","key":"10.1016\/j.psychres.2018.02.013_bib56","doi-asserted-by":"crossref","first-page":"e0135059","DOI":"10.1371\/journal.pone.0135059","article-title":"Psychotropic drug use in Sao Paulo, Brazil--an epidemiological survey","volume":"10","author":"Quintana","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.psychres.2018.02.013_bib57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0272-7358(91)90092-9","article-title":"Expectancy model of fear, anxiety, and panic","volume":"11","author":"Reiss","year":"1991","journal-title":"Clin. Psychol. Rev."},{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1017\/S0141347300011472","article-title":"The importance of behaviour in the maintenance of anxiety and panic: a cognitive account","volume":"19","author":"Salkovskis","year":"2009","journal-title":"Behav. Psychother."},{"issue":"4","key":"10.1016\/j.psychres.2018.02.013_bib59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00213-013-3127-4","article-title":"Benzodiazepine therapy in psychiatric outpatients is associated with deliberate self-poisoning events at emergency departments-a population-based nested case-control study","volume":"229","author":"Shih","year":"2013","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.psychres.2018.02.013_bib60","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1590\/1516-4446-2012-0978","article-title":"Treatment of anxiety disorders by psychiatrists from the American Psychiatric Practice Research Network","volume":"35","author":"Sorsdahl","year":"2013","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"9","key":"10.1016\/j.psychres.2018.02.013_bib61","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.v63n0901","article-title":"Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder","volume":"63","author":"Stahl","year":"2002","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2018.02.013_bib62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/0004867411433969","article-title":"Reconsidering benzodiazepines in the treatment of panic disorder","volume":"46","author":"Starcevic","year":"2012","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2018.02.013_bib63","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1586\/14737175.2014.963057","article-title":"The reappraisal of benzodiazepines in the treatment of anxiety and related disorders","volume":"14","author":"Starcevic","year":"2014","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/YIC.0000000000000100","article-title":"Use of benzodiazepines in obsessive-compulsive disorder","volume":"31","author":"Starcevic","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2018.02.013_bib65","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0887-6185(98)00028-0","article-title":"An expanded anxiety sensitivity index: evidence for a hierarchic structure in a clinical sample","volume":"12","author":"Taylor","year":"1998","journal-title":"J. Anxiety Disord."},{"issue":"9","key":"10.1016\/j.psychres.2018.02.013_bib66","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.addbeh.2008.02.003","article-title":"Social-cognitive predictors of intended and actual benzodiazepine cessation among chronic benzodiazepine users","volume":"33","author":"Ten Wolde","year":"2008","journal-title":"Addict. Behav."},{"issue":"2","key":"10.1016\/j.psychres.2018.02.013_bib67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S1352465804001985","article-title":"Safety-seeking behaviours: fact or function? How can we clinically differentiate between safety behaviours and adaptive coping strategies across anxiety disorders?","volume":"33","author":"Thwaites","year":"2005","journal-title":"Behav. Cogn. Psychother."},{"issue":"2","key":"10.1016\/j.psychres.2018.02.013_bib68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/da.20089","article-title":"Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia","volume":"22","author":"Vasile","year":"2005","journal-title":"Depress. Anxiety"},{"issue":"3","key":"10.1016\/j.psychres.2018.02.013_bib69","first-page":"167","article-title":"Double-blind placebo controlled trial with bromazepam in social phobia","volume":"46","author":"Versiani","year":"1997","journal-title":"J. Bras. Psiquiatr."},{"key":"10.1016\/j.psychres.2018.02.013_bib70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1590\/S0101-81082006000100006","article-title":"Adapta\u00e7\u00e3o transcultural para o portugu\u00eas do Social Phobia Inventory (SPIN) para utiliza\u00e7\u00e3o entre estudantes adolescentes","volume":"28","author":"Vilete","year":"2006","journal-title":"Rev. De. Psiquiatr. do Rio Gd. do Sul"},{"key":"10.1016\/j.psychres.2018.02.013_bib71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-244X-7-18","article-title":"Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review","volume":"7","author":"Watanabe","year":"2007","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib72","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0005-7894(05)80088-7","article-title":"Social phobia: the role of in-situation safety behaviors in maintaining anxiety and negative beliefs","volume":"26","author":"Wells","year":"1995","journal-title":"Behav. Ther."},{"issue":"1","key":"10.1016\/j.psychres.2018.02.013_bib73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1381612023396744","article-title":"As-needed use of benzodiazepines in managing clinical anxiety: incidence and implications","volume":"8","author":"Westra","year":"2002","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.psychres.2018.02.013_bib74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0887-6185(02)00091-9","article-title":"Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia","volume":"16","author":"Westra","year":"2002","journal-title":"J. Anxiety Disord."},{"issue":"2","key":"10.1016\/j.psychres.2018.02.013_bib75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.janxdis.2012.11.004","article-title":"National trends of psychotropic medication use among patients diagnosed with anxiety disorders: results from medical expenditure panel survey 2004\u20132009","volume":"27","author":"Wu","year":"2013","journal-title":"J. Anxiety Disord."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117312672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117312672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T14:37:33Z","timestamp":1570718253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178117312672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":75,"alternative-id":["S0165178117312672"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2018.02.013","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of benzodiazepine use in a transdiagnostic sample of panic disorder, social anxiety disorder, and obsessive-compulsive disorder patients","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2018.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}